LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 148

Search options

  1. Article ; Online: TOMM40 '523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOEɛ3 Homozygotes.

    Watts, Amber / Haneline, Stephen / Welsh-Bohmer, Kathleen A / Wu, Jingtao / Alexander, Robert / Swerdlow, Russell H / Burns, Daniel K / Saunders, Ann M

    Journal of Alzheimer's disease : JAD

    2023  Volume 95, Issue 4, Page(s) 1697–1707

    Abstract: Background: TOMM40 '523 has been associated with cognitive performance and risk for developing Alzheimer's disease independent of the effect of APOE genotype. Few studies have considered the longitudinal effect of this genotype on change in cognition ... ...

    Abstract Background: TOMM40 '523 has been associated with cognitive performance and risk for developing Alzheimer's disease independent of the effect of APOE genotype. Few studies have considered the longitudinal effect of this genotype on change in cognition over time.
    Objective: Our objective was to evaluate the relationship between TOMM40 genotype status and change in cognitive performance in the TOMMORROW study, which was designed to prospectively evaluate an algorithm that includes TOMM40 '523 for genetic risk for conversion to mild cognitive impairment.
    Methods: We used latent growth curve models to estimate the effect of TOMM40 allele carrier (short, very long) status on the intercept and slope of change in cognitive performance in four broad cognitive domains (attention, memory, executive function, and language) and a combined overall cognitive score over 30 months.
    Results: TOMM40 very long allele carriers had significantly lower baseline performance for the combined overall cognitive function score (B = -0.088, p = 0.034) and for the executive function domain score (B = -0.143, p = 0.013). Slopes for TOMM40 very long carriers had significantly greater increases over time for the executive function domain score only. In sensitivity analyses, the results for executive function were observed in participants who remained clinically stable, but not in those who progressed clinically over the study duration.
    Conclusions: Our results add to the growing body of evidence that TOMM40, in the absence of APOEɛ4, may contribute to cognitive changes with aging and dementia and support the view that mitochondrial function is an important contributor to Alzheimer's disease risk.
    MeSH term(s) Humans ; Homozygote ; Alzheimer Disease/genetics ; Executive Function ; Genotype ; Cognitive Dysfunction/genetics ; Cognition ; Apolipoproteins E/genetics ; Mitochondrial Precursor Protein Import Complex Proteins
    Chemical Substances Apolipoproteins E ; TOMM40 protein, human ; Mitochondrial Precursor Protein Import Complex Proteins
    Language English
    Publishing date 2023-09-06
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-230066
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Scheltens ratings, clinical white matter hyperintensities and executive functioning in the Cache County Memory Study.

    Farrer, Thomas J / Bigler, Erin D / Tsui-Caldwell, Yoko H W / Abildskov, Tracy J / Tschanz, JoAnn T / Welsh-Bohmer, Kathleen A

    Applied neuropsychology. Adult

    2023  , Page(s) 1–7

    Abstract: Objective: Examine the association between neuropsychologically assessed executive function and clinically identifiable white matter burden from magnetic resonance imaging, using a visual rating system (Scheltens Rating System) applied to the Cache ... ...

    Abstract Objective: Examine the association between neuropsychologically assessed executive function and clinically identifiable white matter burden from magnetic resonance imaging, using a visual rating system (Scheltens Rating System) applied to the Cache County Memory Study (CCMS) archival database.
    Method: We used the Scheltens Ratings Scale to quantify white matter lesion burden in the CCMS sample and used this metric as a predictor of executive function. The sample included 60 individuals with dementia and 13 healthy controls.
    Results: Higher Scheltens ratings were associated with poorer task performance on an Executive Function composite score of common neuropsychological tests. This association held true for both controls and dementing cases.
    Conclusions: The current findings support extensive prior literature demonstrating the association between brain vascular health determined by white matter burden and clinical outcomes based on neuropsychological assessment of cognitive performance.
    Language English
    Publishing date 2023-12-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2673736-X
    ISSN 2327-9109 ; 2327-9095
    ISSN (online) 2327-9109
    ISSN 2327-9095
    DOI 10.1080/23279095.2023.2287140
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Assessment of Neuropsychological Function in Veterans With Blast-Related Mild Traumatic Brain Injury and Subconcussive Blast Exposure.

    Clausen, Ashley N / Bouchard, Heather C / Welsh-Bohmer, Kathleen A / Morey, Rajendra A

    Frontiers in psychology

    2021  Volume 12, Page(s) 686330

    Abstract: Objective: ...

    Abstract Objective:
    Language English
    Publishing date 2021-06-28
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2563826-9
    ISSN 1664-1078
    ISSN 1664-1078
    DOI 10.3389/fpsyg.2021.686330
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Remote self-administration of digital cognitive tests using the Brief Assessment of Cognition: Feasibility, reliability, and sensitivity to subjective cognitive decline.

    Atkins, Alexandra S / Kraus, Michael S / Welch, Matthew / Yuan, Zhenhua / Stevens, Heather / Welsh-Bohmer, Kathleen A / Keefe, Richard S E

    Frontiers in psychiatry

    2022  Volume 13, Page(s) 910896

    Abstract: Cognitive impairment is a common and pervasive feature of etiologically diverse disorders of the central nervous system, and a target indication for a growing number of symptomatic and disease modifying drugs. Remotely acquired digital endpoints have ... ...

    Abstract Cognitive impairment is a common and pervasive feature of etiologically diverse disorders of the central nervous system, and a target indication for a growing number of symptomatic and disease modifying drugs. Remotely acquired digital endpoints have been recognized for their potential in providing frequent, real-time monitoring of cognition, but their ultimate value will be determined by the reliability and sensitivity of measurement in the populations of interest. To this end, we describe initial validation of remote self-administration of cognitive tests within a regulatorily compliant tablet-based platform. Participants were 61 older adults (age 55+), including 20 individuals with subjective cognitive decline (SCD). To allow comparison between remote (in-home) and site-based testing, participants completed 2 testing sessions 1 week apart. Results for three of four cognitive domains assessed demonstrated equivalence between remote and site-based tests, with high cross-modality ICCs (absolute agreement) for Symbol Coding (ICC = 0.75), Visuospatial Working Memory (ICC = 0.70) and Verbal Fluency (ICC > 0.73). Group differences in these domains were significant and reflected sensitivity to objective cognitive impairment in the SCD group for both remote and site-based testing (
    Language English
    Publishing date 2022-08-24
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2564218-2
    ISSN 1664-0640
    ISSN 1664-0640
    DOI 10.3389/fpsyt.2022.910896
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Raising Awareness of Alzheimer's Disease and Dementia in Native Americans in North Carolina.

    Welsh-Bohmer, Kathleen A / Byrd, Goldie Smith / Dewees, Rachel / Bozoki, Andrea C / Martin, Patrick M / Plassman, Brenda / Price, S Russ

    North Carolina medical journal

    2022  Volume 83, Issue 1, Page(s) 77–78

    MeSH term(s) Alzheimer Disease/epidemiology ; American Indians or Alaska Natives ; Humans ; North Carolina/epidemiology ; Risk Factors
    Language English
    Publishing date 2022-01-03
    Publishing country United States
    Document type Letter
    ZDB-ID 422795-5
    ISSN 0029-2559
    ISSN 0029-2559
    DOI 10.18043/ncm.83.1.77
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Nomenclature for Perioperative Cognitive Disorders: Comment.

    Mathew, Joseph P / Welsh-Bohmer, Kathleen A / Newman, Mark F

    Anesthesiology

    2019  Volume 131, Issue 2, Page(s) 443–444

    MeSH term(s) Cognition ; Cognition Disorders ; Humans
    Language English
    Publishing date 2019-08-26
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 269-0
    ISSN 1528-1175 ; 0003-3022
    ISSN (online) 1528-1175
    ISSN 0003-3022
    DOI 10.1097/ALN.0000000000002831
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Influence of mild cognitive impairment on patient and care partner decision-making for acute ischemic stroke.

    Blair, Emilie M / Reale, Bailey K / Zahuranec, Darin B / Forman, Jane / Langa, Kenneth M / Giordani, Bruno J / Plassman, Brenda L / Welsh-Bohmer, Kathleen A / Wang, Jing / Kollman, Colleen D / Levine, Deborah A

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

    2023  Volume 32, Issue 6, Page(s) 107068

    Abstract: Goals: Evidence suggests that patients with mild cognitive impairment (MCI) receive fewer treatments for acute ischemic stroke and other cardiovascular diseases than patients with normal cognition. Little is known about how patient and care partner ... ...

    Abstract Goals: Evidence suggests that patients with mild cognitive impairment (MCI) receive fewer treatments for acute ischemic stroke and other cardiovascular diseases than patients with normal cognition. Little is known about how patient and care partner preferences for ischemic stroke treatment differ between the patient population with MCI and the population with normal cognition. This study aimed to understand how patient MCI diagnosis influences patient and care partner decision-making for acute ischemic stroke treatments.
    Methods: Multi-center qualitative study using in-person semi-structured interviews with 20 MCI and normal cognition patient-care partner dyads using a standard guide. The present study reports results on patient and care partner preferences for a clinical vignette patient to receive three non-invasive treatments (intravenous tissue plasminogen activator, inpatient rehabilitation, and secondary preventive medications) and two invasive treatments (feeding tube and carotid endarterectomy) after acute ischemic stroke. We used qualitative content analysis to identify themes.
    Findings: We identified three major themes: (1) Patients with MCI desired non-invasive treatments after stroke, similar to patients with normal cognition and for similar reasons; (2) Patients with MCI expressed different preferences than patients with normal cognition for two invasive treatments after stroke: carotid endarterectomy and feeding tube placement; and (3) Patients with MCI expressed more skepticism of the stroke treatment options and less decisiveness in decision-making than patients with normal cognition.
    Conclusions: These results suggest that patient MCI diagnosis may contribute to differences in patient and care partner preferences for invasive treatments after stroke, but not for non-invasive treatments.
    MeSH term(s) Humans ; Tissue Plasminogen Activator ; Ischemic Stroke/complications ; Caregivers ; Cognitive Dysfunction/diagnosis ; Cognitive Dysfunction/therapy ; Cognitive Dysfunction/epidemiology ; Stroke/diagnosis ; Stroke/therapy ; Stroke/complications
    Chemical Substances Tissue Plasminogen Activator (EC 3.4.21.68)
    Language English
    Publishing date 2023-03-31
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1131675-5
    ISSN 1532-8511 ; 1052-3057
    ISSN (online) 1532-8511
    ISSN 1052-3057
    DOI 10.1016/j.jstrokecerebrovasdis.2023.107068
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Decision making in clinical trials: Interim analyses, innovative design, and biomarkers.

    Welsh-Bohmer, Kathleen A / Kerchner, Geoffrey A / Dhadda, Shobha / Garcia, Miguel / Miller, David S / Natanegara, Fanni / Raket, Lars Lau / Robieson, Weining / Siemers, Eric R / Carrillo, Maria C / Weber, Christopher J

    Alzheimer's & dementia (New York, N. Y.)

    2023  Volume 9, Issue 4, Page(s) e12421

    Abstract: The efficient and accurate execution of clinical trials testing novel treatments for Alzheimer's disease (AD) is a critical component of the field's collective efforts to develop effective disease-modifying treatments for AD. The lengthy and ... ...

    Abstract The efficient and accurate execution of clinical trials testing novel treatments for Alzheimer's disease (AD) is a critical component of the field's collective efforts to develop effective disease-modifying treatments for AD. The lengthy and heterogeneous nature of clinical progression in AD contributes to the challenges inherent in demonstrating a clinically meaningful benefit of any potential new AD therapy. The failure of many large and expensive clinical trials to date has prompted a focus on optimizing all aspects of decision making, to not only expedite the development of new treatments, but also maximize the value of the information that each clinical trial yields, so that all future clinical trials (including those that are negative) will contribute toward advancing the field. To address this important topic the Alzheimer's Association Research Roundtable convened December 1-2, 2020. The goals focused around identifying new directions and actionable steps to enhance clinical trial decision making in planned future studies.
    Language English
    Publishing date 2023-10-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2832891-7
    ISSN 2352-8737 ; 2352-8737
    ISSN (online) 2352-8737
    ISSN 2352-8737
    DOI 10.1002/trc2.12421
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Cognitive and Cerebrospinal Fluid Alzheimer's Disease-related Biomarker Trajectories in Older Surgical Patients and Matched Nonsurgical Controls.

    Reese, Melody / Wong, Megan K / Cheong, Vanessa / Ha, Christine I / Cooter Wright, Mary / Browndyke, Jeffrey / Moretti, Eugene / Devinney, Michael J / Habib, Ashraf S / Moul, Judd W / Shaw, Leslie M / Waligorska, Teresa / Whitson, Heather E / Cohen, Harvey J / Welsh-Bohmer, Kathleen A / Plassman, Brenda L / Mathew, Joseph P / Berger, Miles

    Anesthesiology

    2024  Volume 140, Issue 5, Page(s) 963–978

    MeSH term(s) Humans ; Aged ; Alzheimer Disease ; Amyloid beta-Peptides ; tau Proteins ; Cognitive Dysfunction/diagnosis ; Cognition ; Biomarkers ; Peptide Fragments
    Chemical Substances Amyloid beta-Peptides ; tau Proteins ; Biomarkers ; Peptide Fragments
    Language English
    Publishing date 2024-02-06
    Publishing country United States
    Document type Journal Article
    ZDB-ID 269-0
    ISSN 1528-1175 ; 0003-3022
    ISSN (online) 1528-1175
    ISSN 0003-3022
    DOI 10.1097/ALN.0000000000004924
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Defining "prodromal" Alzheimer's disease, frontotemporal dementia, and Lewy body dementia: are we there yet?

    Welsh-Bohmer, Kathleen A

    Neuropsychology review

    2008  Volume 18, Issue 1, Page(s) 70–72

    MeSH term(s) Alzheimer Disease/psychology ; Dementia/psychology ; Humans ; Lewy Body Disease/psychology ; Terminology as Topic
    Language English
    Publishing date 2008-03-08
    Publishing country United States
    Document type Editorial ; Introductory Journal Article
    ZDB-ID 1062572-0
    ISSN 1573-6660 ; 1040-7308
    ISSN (online) 1573-6660
    ISSN 1040-7308
    DOI 10.1007/s11065-008-9057-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top